United Therapeutics (UTHR) Current Assets (2009 - 2026)
United Therapeutics (UTHR) posted Current Assets of $2.9 billion for Q1 2026, down 22.43% sequentially from $3.7 billion in Q4 2025, and down 27.1% YoY from $3.9 billion in Q1 2025.
United Therapeutics (UTHR) Current Assets (2009 - 2026) Analysis & Trends
United Therapeutics has reported Current Assets for 18 years, with the latest figure at $2.9 billion in Q1 2026.
- Quarterly Current Assets fell 27.1% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 27.1% YoY) and the FY2025 annual result came in at $3.7 billion, down 4.42% from the prior year.
- Current Assets retreated to $2.9 billion in Q1 2026 per UTHR's latest filing, from $3.7 billion in the prior quarter.
- Over five years, Current Assets peaked at $4.0 billion in Q3 2024 and troughed at $2.6 billion in Q1 2022.
- A 5-year average of $3.4 billion and a median of $3.5 billion in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2026: Current Assets soared 45.48% in 2022, then retreated 27.1% in 2026.
- Over 5 years, Current Assets stood at $3.4 billion in 2022, then increased by 5.05% to $3.6 billion in 2023, then climbed by 9.09% to $3.9 billion in 2024, then retreated by 4.42% to $3.7 billion in 2025, then fell by 22.43% to $2.9 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $2.9 billion, $3.7 billion, and $3.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Bn |
| Mar 31, 2026 | 2.87 Bn |
| Dec 31, 2025 | 3.70 Bn |
| Sep 30, 2025 | 3.49 Bn |
| Jun 30, 2025 | 3.83 Bn |
| Mar 31, 2025 | 3.94 Bn |
| Dec 31, 2024 | 3.87 Bn |
| Sep 30, 2024 | 4.00 Bn |
| Jun 30, 2024 | 3.62 Bn |
| Mar 31, 2024 | 3.25 Bn |
| Dec 31, 2023 | 3.55 Bn |
| Sep 30, 2023 | 3.46 Bn |
| Jun 30, 2023 | 3.21 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.38 Bn |
| Sep 30, 2022 | 3.06 Bn |
| Jun 30, 2022 | 2.68 Bn |
| Mar 31, 2022 | 2.59 Bn |
| Dec 31, 2021 | 2.32 Bn |
| Sep 30, 2021 | 2.39 Bn |